Annual Drug Patent Expirations for LUTATHERA
Lutathera is a drug marketed by Aaa Usa Inc and is included in one NDA. It is available from one supplier. There are two patents protecting this drug.
Drug patent litigation for LUTATHERA.
This drug has thirty-three patent family members in fifteen countries.
The generic ingredient in LUTATHERA is lutetium lu 177 dotatate. One supplier is listed for this compound. Additional details are available on the lutetium lu 177 dotatate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com